# Imaging - Advancing Biomarker Research for Alzheimer’s Disease Diagnosis

29 Apr 25

blog

# Imaging - Advancing Biomarker Research for Alzheimer’s Disease Diagnosis

Robin Wolz

Alzheimers Disease

PET

Bio-Hermes

Amyloid PET

[  ](https://x.com/intent/tweet?url=https://ixico.com/news-and-resources/blog/imagingadvancing-biomarker-research-for-alzheimers-disease-diagnosis/) [  ](https://bsky.app/intent/compose?text=https://ixico.com/news-and-resources/blog/imagingadvancing-biomarker-research-for-alzheimers-disease-diagnosis/) [  ](https://www.facebook.com/sharer/sharer.php?u=https://ixico.com/news-and-resources/blog/imagingadvancing-biomarker-research-for-alzheimers-disease-diagnosis/) [  ](https://www.linkedin.com/shareArticle?mini=true&url=https://ixico.com/news-and-resources/blog/imagingadvancing-biomarker-research-for-alzheimers-disease-diagnosis/) <a class="trigger-share-window d-md-none">  </a>

![Your Partner in Parkinson's Disease Imaging Analysis and Operations Solutions (2)](/assets/blog-images/Your-Partner-in-Parkinsons-Disease-Imaging-Analysis-and-Operations-Solutions-2__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp)**Imaging: Advancing Biomarker Research for Alzheimer's Disease Diagnosis**

In an article published in the latest edition of the Journal for Clinical Studies, IXICO’s Chief Scientific Officer Robin Wolz outlines how data from the landmark Bio-Hermes study, sponsored by the Global Alzheimer's Platform Foundation (GAP) and supported by IXICO as imaging partner, can help better understand the complementary use of amyloid positron emission tomography (PET) and blood based biomarkers (BBMs) in the diagnosis of Alzheimer‘s disease (AD).

Analysis of the Bio-Hermes data validates utility of a two-stage screening process where initial BBM tests are followed by amyloid PET scans for ambiguous cases. This approach enhances trial efficiency by reducing PET screen failure rates and improving the identification of suitable candidates for clinical trials.

By examining the interplay between imaging and BBMs, the article highlights how BBMs offer a more accessible, less invasive, and cost-effective alternative where appropriate, while acknowledging the need for a gold-standard assessment from PET in certain cases.

**Read the full editorial [here](https://issuu.com/senglobal1/docs/jcs_-_volume_17_issue_1)**

[ Back to Blog  ](/news-and-resources/blog/)

### Recents

![Beyond Diagnosis: 8 MRI and PET Biomarkers Shaping Alzheimer's Clinical Trials](/assets/blog-images/Alzheimers-biomarkers__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp)

29 Sep 26

blog

[Beyond Diagnosis: 8 MRI and PET Biomarkers Shaping Alzheimer's Clinical Trials](/news-and-resources/blog/pet-mri-biomarkers-alzheimers-clinical-trials/)

[White matter hyperintensities: A precision neurology tool for Alzheimer’s patient stratification and improved trial sensitivity? ](/news-and-resources/blog/white-matter-hyperintensities-a-precision-neurology-tool-for-alzheimers-patient-stratification-and-improved-trial-sensitivity/)

[Neuromelanin MRI: An Early, Longitudinal Biomarker for Parkinson’s Disease](/news-and-resources/blog/neuromelanin-mri-an-early-longitudinal-biomarker-for-parkinsons-disease/)

[From Information to Intelligence: New Platform Identity Explained](/news-and-resources/blog/from-information-to-intelligence-bram-goodren-ceo-of-ixico-explains-the-new-identity-of-the-ixi-platform-and-why-it-matters/)

[Advancing HD Clinical Trials with Automated Imaging: What the Latest Research Shows](/news-and-resources/blog/advancing-hd-clinical-trials-with-automated-imaging-what-the-latest-research-shows/)

### Library

[November 2026](/news-and-resources/blog/archive/2026/11/)

[October 2026](/news-and-resources/blog/archive/2026/10/)

[September 2026](/news-and-resources/blog/archive/2026/09/)

[July 2026](/news-and-resources/blog/archive/2026/07/)

[June 2026](/news-and-resources/blog/archive/2026/06/)

[May 2026](/news-and-resources/blog/archive/2026/05/)

[April 2026](/news-and-resources/blog/archive/2026/04/)

[March 2026](/news-and-resources/blog/archive/2026/03/)

[February 2026](/news-and-resources/blog/archive/2026/02/)

[January 2026](/news-and-resources/blog/archive/2026/01/)

[2025](/news-and-resources/blog/archive/2025/)

[2024](/news-and-resources/blog/archive/2024/)

[2023](/news-and-resources/blog/archive/2023/)

[2022](/news-and-resources/blog/archive/2022/)

[2021](/news-and-resources/blog/archive/2021/)

[2020](/news-and-resources/blog/archive/2020/)

[2019](/news-and-resources/blog/archive/2019/)